drugset / Trial / NCT06997952
Febuxostat Effect on Chronic Kidney Disease Progression And Carotid Intima-Media Thickness
RandomizedParallel-groupSingle-blindOther
Summary
This study aimed to evaluate the impact of febuxostat on both carotid intima-media thickness and disease progression in individuals with chronic kidney disease
Timeline
- Start
- 2024-05-24
- Primary completion
- 2024-08-24
- Completion
- 2024-08-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Febuxostat | Small molecule | 40 mg | — |
Indications
No indication recorded.